ABSTRACT We studied the effects of procainamide and N-acetylprocainamide (NAPA) in a conscious dog preparation of atrial flutter resulting from circus movement around the tricuspid orifice. We also recorded transmembrane potentials of atrial tissues from the circus path in vitro. In 12 instrumented dogs, average flutter cycle length was 157 msec, the duration of the excitable gap was 73 msec, and conduction velocity was 0.75 m/sec. At 4 and 8 mg/kg, procainamide moderately prolonged cycle length, but did not terminate the flutter. At a cycle length of 300 msec procainamide increased effective refractory period (ERP) December 1987 lamina.4 The reentrant excitation causing a flutter can be induced, reset, and terminated by premature stimulation. Furthermore, there is a partially excitable gap in the circus path and thus the rhythm can be entrained by programmed stimulation.3
THE MECHANISM for atrial flutter in humans is still uncertain. Evidence for either circus movement or ectopic impulse origin as a mechanism for flutter has been reported, as reviewed by Boineau .' Rosenblueth and Garcia-Ramos2 developed a preparation of reentrant flutter in the canine heart by creating an obstacle to conduction in the intercaval region of the right atrium. Recently we modified this preparation and studied the mechanism for this type of flutter in detail. 3 We made a Y-shaped lesion, whichconsisted ofan intercaval incision and a contiguous one that branched toward the right atrial appendage. This rendered the atria more susceptible to persistent flutter than did the intercaval lesion alone. We have shown that flutter in this preparation is due to circus movement occurring in the atrial tissues above the tricuspid ring, the supravalvular lamina. 4 The reentrant excitation causing a flutter can be induced, reset, and terminated by premature stimulation. Furthermore, there is a partially excitable gap in the circus path and thus the rhythm can be entrained by programmed stimulation. 3 In this preparation of atrial flutter the path for circus movement is provided by electrophysiologically normal tissue4' 5; the reentrant impulse propagates in an anatomically discrete circuit and the arrhythmia can be studied over the long term in conscious animals. The preparation is thus suitable for study of the mechanism of action of antiarrhythmic agents. We do not argue here that flutter in our preparation results from the same mechanisms as flutter in the diseased human heart; indeed, in the latter different mechanisms probably operate in different cases. Nevertheless, our findings will be applicable to arrhythmias that result from the mechanism operative in our preparation. At (table 2).   TABLE 2 Flutter was terminated in all cases by a dose of 16 or 32 mg/kg. The cycle length reached a peak value within 2 min at the end of injection and then flutter terminated abruptly (figure 2). In this example there was no significant change in the cycle length of the flutter immediately before termination and propagation in the reentrant path terminated somewhere in the anterior free wall during a cycle that otherwise resembled the prior cycles. In most cases, the last cycle of the flutter was slightly prolonged. In no case did a premature impulse appear before flutter converted to sinus rhythm.
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Abbreviations are as in tables 1 and 2.
ASignificantly different from control (p < .05). dependence of recovery from inactivation), the duration of the excitable gap again might decrease. Termination of reentry would not necessarily occur when the duration of the action potential or ERP approached the value of the cycle length, but rather when blockade of fast channels rendered the impulse incapable of propagating in tissues that had not sufficiently recovered excitability and responsiveness. Also, if it is correct to assume that termination of the reentrant excitation occurs when the safety factor for propagation becomes too low, one might predict that a drug causing block of fast channels would terminate the arrhythmia at a shorter cycle length than one, such as NAPA, that acts mainly to increase action potential duration.
There are factors that might complicate this type of analysis. The elfects of both drugs may be cycle length dependent. The degree to which NAPA increases APD ASignificantly different from control (p < .05).
CIRCULATION
in Purkinje fibers7 is strongly dependent on cycle length and thus the intensity of this drug effect might be expected to increase with cycle length. Fortunately, our data for atrial muscle (table 7) do not show a strong dependence of the drug-induced change in action potential duration on cycle length (prolongation of 1 1% or 16 msec at a cycle length of 1000 msec and 16% or 16 msec at a cycle length of 300 msec). Procainamide is known to show use dependence in some tissues12;
thus, as cycle length increases the degree of fast channel block would be expected to decrease. Once again our data (table 4) showed no strong evidence of use dependence (A Vmax = 15% at a cycle length of 1000 msec and 19% at a cycle length of 300 msec) for atrial muscle within the range of cycle lengths we tested. Finally, the percent prolongation of action potentials by procainamide is not strongly dependent on cycle length (A APD = 16% or 22 msec at a cycle length of 1000 msec and 20% or 19 msec at a cycle length of 300 msec). These findings help justify our simplified assumptions.
Evaluation of the suitability of the preparation. Another important consideration is the suitability of our preparation to test the mode of action of antiarrhythmic drugs. The data in table 1 and data published previously3 strongly support the idea that this preparation of atrial flutter is consistent in its behavior. The cycle length of the induced flutter varies only slightly with time during an experiment and varies minimally when flutter is induced at different times in the same dog over periods of months. Also, the arrhythmia is quite comparable among the 12 dogs in the series. The relationship of the duration of the FERP to the flutter cycle length under control conditions is somewhat more variable. The fraction of the flutter cycle length occupied by the ERP was not related to the size of the tricuspid ring, as one might expect, and because of the narrow range of cycle lengths under control conditions could not be shown to vary with cycle length. When values from repeated trials on the same dog were compared (tables 3 and 6), in three of four cases, when the cycle length was the same the value for FERP was the same, while in one animal it decreased. In one animal when cycle length increased so did FERP and in another when cycle length decreased FERP also decreased. No firm conclusion can be reached, but these findings suggest that variations in vagal tone in the conscious dog influence both cycle length during flutter and FERP, probably through effects on APD. The relationship between the circumference of the tricuspid ring and conduction velocity ( figure 1) is not sufficient to precisely define how velocity depends on path lengths Vol. 76, No. 6, December 1987 since we have no data on very small rings (<10 cm) and only limited data on quite large rings. If the rings were large enough, velocity would become independent of path length. The interesting finding is the fairly steep dependence of velocity on path length for rings between 10 and 13 (or perhaps 16) cm in circumference. This finding strongly supports our earlier conclusion3 that in this preparation during flutter the impulse propagates in tissues that have recovered only incompletely from prior activity. Very large rings might provide an exception. The data also imply that druginduced termination might be more likely, or attained at lower doses, in small dogs. We do not have sufficient data to explore this possibility.
Studies in isolated tissues. We studied the transmembrane potentials recorded from tissues that constitute the circus path for several reasons. We hoped to demonstrate that at each site selected the fibers developed fast responses with comparable characteristics; our limited data support this expectation. One interesting finding was the quite high value for Vma, in these fibers; the significance of this needs to be determined. We also wished to determine the response of these tissues to rapid pacing under control conditions and after exposure to procainamide or NAPA. An unexpected finding was the small but consistent decrease in Vmax under control conditions when the cycle length was progressively decreased from 1000 to 300 msec. We were unable to obtain reliable data for still shorter cycle lengths, but the findings at a cycle length of 300 msec suggest that very likely there is incomplete recovery of responsiveness in the circus path in the range of cycle lengths observed during flutter under control conditions. The data describing the response to procainamide and NAPA present several unexpected findings. We failed to demonstrate any greater fractional depression of Vmax at short than at long cycle lengths after administration of procainamide, as would have been expected for a drug showing prominent use dependence in other tissues. 2 Also, the two drugs caused comparable prolongation of the action potential. This finding may be dose dependent since the 20% prolongation caused by procainamide at a cycle length of 300 msec was comparable to the 20% increase in ERP in vivo at a dose of 8 mg/kg, whereas the 16% prolongation of the action potential by NAPA at the same cycle length was comparable to the 14% increase in ERP in vivo at a dose of 16 mg/kg. In spite of this, the studies on the isolated tissues support our assumptions that procainamide blocks fast channels and prolongs action potential and refractoriness, whereas NAPA does not block fast channels but prolongs action potential and refractoriness. figure  6 in Frame et al . 3) This suggests that the cycle length of the flutter is equal to the FRP. The wave length of functional refractoriness thus may be constantly adjusted in terms of the cycle length and vice versa. This might be intuitively obvious for circus movement whenever the reentrant impulse propagates in tissues that have not fully recovered from a prior impulse; i.e., the impulse will propagate as rapidly as possible.
If these assumptions are correct it is possible, with one proviso, to make an estimate of one mechanism for termination of flutter in this preparation. The added assumption is that in the tissues of the supravalvular lamina there is no period of supernormal conduction. 17 With supernormality of conduction impulse origin either earlier or later during phase 3 would be associated with slower propagation. With this limit one might ask what changes would result from an abrupt local slowing of conduction during a single cycle. Because of the local slowing tissues in advance of the impulse would be allowed more time to repolarize. As a result, when the impulse entered these more fully repolarized tissues conduction velocity would increase. The increase in conduction velocity would increase LFRP and this might lead to block of propagation. We do not have data permitting a quantitative evaluation of this possibility. Nevertheless, we judge that a mechanism of this sort is a possible cause of termination of circus movement because in most instances in this study the final cycle of reentry was slightly prolonged and the drug-induced termination of flutter was abrupt.
The conclusion seems inescapable that in this preparation of reentrant excitation due to circus movement drugs like procainamide and NAPA exert certain actions that can be predicted from studies on transmembrane potentials but that the mechanism for antiarrhythmic action (termination of circus movement) cannot be predicted in any simple way from knowledge of effects in vitro on action potential duration, Vmax, and conduction velocity. It is possible that each drug acted more strongly on a restricted segment of the circus path than on the remainder and that failure of conduction in this segment terminated the arrhythmias. This seems unlikely since we did not record any local slowing of conduction (revealed as an increase in interelectrode conduction time) before termination, and for different episodes of arrhythmia, conduction failed at different sites in the circus path. Since in most instances termination followed a slight increase in length of the preceding cycle, it is possible that block occurred for this reason. Thus, after a slowing of conduction the impulse entered more fully recovered tissues and conduction velocity increased inappropriately so that the impulse then entered the next segment of the ring before those tissues could sustain propagation.
Implications for atrial flutter in humans. It has been suggested that because type 1 flutter in different patients shows a narrow range of cycle lengths and a consistent electrocardiographic waveform the arrhythmia probably results from reentry due to circus movement in a structure that has the same location and is of similar size in different individuals.1' 18 Our data suggest that the requirement for constant path length is not necessary if the reentrant impulse propagates in tissues that have not completely recovered from prior activity. As shown in figure 1 , an 81% difference in path length is associated with an 80% difference in conduction velocity and thus an almost invariant cycle length during flutter (see table 1 ). A similar relationship most likely would apply for circus movement in other tissues located around the perimeter of inexcitable obstacles as long as the impulse was propagating in tissues that had not yet recovered full excitability and responsiveness.
We realize that our findings in this preparation of atrial flutter are not necessarily applicable to flutter of the diseased human atria because, even though most data support reentry as the predominant cause of atrial flutter in humans,1' 19, 20 they provide little information on the nature of the circus path. The actions of antiarrhythmic drugs clearly will be influenced by the functional and anatomic properties of the path. We believe, however, that our findings are applicable to reentrant rhythms that result from the mechanism operative in our preparation.
